(Q40904743)

24 September 2017

Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum (English)

1 reference

24 September 2017

1 reference

Sereno D

1

1 reference

PubMed ID

10643904

24 September 2017

Holzmuller P

series ordinal

2

1 reference

PubMed ID

10643904

24 September 2017

Lemesre JL

series ordinal

3

1 reference

24 September 2017

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

74

1 reference

24 September 2017

1

1 reference

24 September 2017

25-31

1 reference

Amphotericin B Pharmacokinetics in Humans

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Complete developmental cycle of Leishmania mexicana in axenic culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Axenic cultivation and characterization of Leishmania mexicana amastigote-like forms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Axenic culture of Leishmania amastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

An in Vitro Model for Investigation of Chemotherapeutic Agents in Leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Leishmania mexicana: uptake of sodium stibogluconate (Pentostam) and pentamidine by parasite and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

A comparative study of Leishmania mexicana amastigotes and promastigotes, enzyme activities and subcellular locations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Three dimensional structure of the Leishmania amastigote as revealed by computer-aided reconstruction from serial sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Leishmania mexicana: purine-metabolizing enzymes of amastigotes and promastigotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Mechanisms of drug resistance in Leishmania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

The amplified H circle of methotrexate-resistant leishmania tarentolae contains a novel P-glycoprotein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Phenotypic characterization of Leishmania mexicana pentamidine-resistant promastigotes. Modulation of the resistance during in-vitro developmental life cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Multidrug resistance and P-glycoproteins in parasitic protozoa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2899%2900048-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-706X(99)00048-0

1 reference

24 September 2017

1 reference

PubMed ID

10643904